Biofrontera (BFRI) Stock Analysis
NASDAQHealthcareMedical - Pharmaceuticals
What Biofrontera does
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.
Key metrics
ETFs linked to BFRI
Broad-market and Healthcare sector ETFs an investor holding Biofrontera is often also exposed to. Open an ETF page to see its actual top holdings.
PortView Portfolio Insights
PortView analyzes how BFRI fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.
Analyze BFRI in PortView →Similar companies
Frequently asked questions
- What is the ticker symbol for Biofrontera?
- Biofrontera trades under the ticker BFRI on NASDAQ.
- Which exchange is BFRI listed on?
- BFRI is listed on NASDAQ.
- What sector does Biofrontera operate in?
- Biofrontera is classified in the Healthcare sector (Medical - Pharmaceuticals industry).
- How can PortView help analyze BFRI in a portfolio?
- PortView shows BFRI's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.
The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.